| Date Filed | Type | Description |
| 03/01/2023 |
SC 13D/A
| Sofinnova Venture Partners X, L.P. reports a 0% stake in CinCor Pharma, Inc. |
| 02/27/2023 |
4
| HEALY JAMES (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Sold 6,000 shares
@ $14.32, valued at
$85.9k
Unknown transaction of 9,803 shares
@ $0
Disposed/sold 19,608 shares
@ $0
Unknown transaction of 6,073,949 shares
@ $0 |
|
| 02/08/2023 |
4
| Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Bought 285,714 shares
@ $7, valued at
$2M
|
|
| 08/19/2022 |
SC 13D/A
| Sofinnova Venture Partners X, L.P. reports a 14.3% stake in CinCor Pharma, Inc. |
| 08/15/2022 |
4
| Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Bought 500,000 shares
@ $30, valued at
$15M
|
|
| 02/14/2022 |
SC 13D/A
| Sofinnova Venture Partners X, L.P. reports a 5.2% stake in Y-mAbs Therapeutics, Inc. |
| 02/14/2022 |
4
| Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Bought 266,666 shares
@ $15, valued at
$4M
|
|
| 01/21/2022 |
SC 13D
| Sofinnova Venture Partners X, L.P. reports a 15.3% stake in CinCor Pharma, Inc. |
| 01/13/2022 |
4
| Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Converted 5,248,949 shares
@ $0
Bought 325,000 shares
@ $16, valued at
$5.2M
Converted 13,571,428 preferred shares
@ $0
Converted 4,275,000 preferred shares
@ $0 |
|
| 01/06/2022 |
3
| Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 3 on CinCor Pharma, Inc. |
| 07/13/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/24/2021 |
SC 13D
| Sofinnova Venture Partners X, L.P. reports a 14.5% stake in Vera Therapeutics, Inc. |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/04/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/16/2021 |
SC 13D
| Sofinnova Venture Partners X, L.P. reports a 8% stake in Bolt Biotherapeutics, Inc. |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/03/2019 |
SC 13D
| Sofinnova Venture Partners X, L.P. reports a 7.4% stake in Karuna Therapeutics, Inc. |
| 10/02/2018 |
SC 13D
| Sofinnova Venture Partners X, L.P. reports a 6.3% stake in Y-mAbs Therapeutics, Inc. |
| 08/23/2016 |
D
| Form D - Notice of Exempt Offering of Securities |